布比卡因注射液致不良反应文献分析

• 药品评价-安全性研究 • 上一篇下一篇

布比卡因注射液致不良反应文献分析

黄迪,陈勇,窦元元

厦门市药品检验所不良反应监测科,厦门市药品检验所不良反应监测科,南京军区福州总医院麻醉科

收稿日期:2014-06-30 修回日期:2014-07-21 出版日期:2014-08-25 发布日期:2014-08-25

Literature Analysis of Adverse Drug Reactions Induced by Bupivacaine Injection

陈勇 and

Department of Adverse reaction monitoring,Xiamen Insititute for Drug Control,Department of Adverse reaction monitoring,Xiamen Insititute for Drug Control,Department of Anesthesiology,Fuzhou General Hospital,Nanjing Military Region

Received:2014-06-30 Revised:2014-07-21 Online:2014-08-25 Published:2014-08-25

摘要/Abstract

摘要： 目的分析布比卡因注射液致药品不良反应的特点和规律,为临床合理用药提供参考。方法以“布比卡因”、“不良反应”等关键词检索中国期刊全文数据库、维普资讯网和万方数据库文献,截至2013年12月共检索到涉及布比卡因注射液致不良反应病例56例,对报告进行统计与分析。结果布比卡因注射液所致不良反应可发生于各个年龄段,多在用药10 min内发生。其不良反应可累及多个系统和器官,主要表现为心血管系统损害、中枢神经系统、呼吸系统和全身性损害等。结论布比卡因注射液所致不良反应多在短时间内发生,应加强临床用药监测,防范不良反应的发生。目前国内说明书存在不良反应信息提示不足的情况,建议相关部门对说明书进行修改和完善。

Abstract: Objective To analyze the characteristics and regularity of adverse drug reactions ( ADR ) induced by Bupivacaine injection and provide basis for clinical rational drug use. Methods With "Bupivacaine","adverse drug reaction" as Keywords, retrieved literatures from CHKI,CQVIP and Wanfang database as of December 2013,232 cases of ADR by Bupivacaine injection were statistically analyzed.Results The ADRs induced by Bupivacaine injection could occur at all ages with a higher incidence of within 10 minutes after administration.ADR involved multiple systems and organs.The main clinical manifestation represented as cardiovascular system(28.10%),central nervous system(26.64%), respiratory system(14.60%) and systemic damage(11.31%),there may be serious death.Conclusion ADR induced by Bupivacaine injection occured mostly in a short period of time. The clinical application should be monitored closely to prevent the occurrence of adverse reactions.The domestic drug package inserts are lack of warnings for ADR information.It is suggested that related administration departments should revise and improve the drug package inserts of Bupivacaine injection.

黄迪,陈勇,窦元元. 布比卡因注射液致不良反应文献分析[J]. .

陈勇 and. Literature Analysis of Adverse Drug Reactions Induced by Bupivacaine Injection[J]. .

参考文献

[1] Heavner JE.Cardiac toxicity of local anesthetics in the intact isolated heart model:a review[J].Reg Anesth PainMed, 2002,27:545-555.
[2] 刘俊杰.现代麻醉学[M].第2版.北京：人民卫生出版社,1997:31.
[3] 张洪钦,王征龙.盐酸布比卡因引起休克1例[J].海峡药学,2009,21(3):170.
[4] 孙京华,杨红.利多卡因和布比卡因球周麻醉毒性反应2例[J].中国眼耳鼻喉科杂志,2002,2(1):42-43.
[5] 杨天明,范新民,钟军.利多卡因改用布比卡因硬膜外麻醉中毒3例[J].广西医科大学学报,2006,23(1):130.
[6] 都大伟,刘涛.局麻药毒性致术后神经损害一例[J].临床麻醉学杂志,2005,21(4):265.
[7] 国家食品药品监督管理总局.盐酸布比卡因注射液[EB/OL]. http://app1.sfda.gov. cn/datasearch/face3/base.jsp.
[8] 39健康网.盐酸布比卡因注射液[EB/OL]. http://ypk.39.net/manual/763973/0/.
[9] 国家药典委员会.中华人民共和国药典临床用药须知(化学药和生物制品卷) [M]. 2005年版.北京:人民卫生出版社,2005:84．
[10] 蔡利峰.罗哌卡因与布比卡因用于腰硬联合麻醉的最佳剂量探讨[J].海峡药学,2013,25(5):154-155.
[11] 贾佳,金立民,杨希革,等.右美托咪定预注对布比卡因心脏毒性的影响[J].中国老年学杂志,2012,32(4):773-774.
[12] 王强,徐礼鲜,陈绍洋,等.丙泊酚对布比卡因中枢及心脏毒性的治疗作用[J].临床麻醉学杂志,2009,25 (10):881-883.
[13] Fortuna A,Fortuna Ade O.Bupivacaine-induced cardiac arrest[J].Anesth Analg,1990,71:561-562.
[14] Li Q,Clark S,Lewis DV,et al.NMDA receptor antagonists disinhibit rat posterior cingulate and retrosplenial cortices: a potential mechanism of neurotoxicity[J]. J Neurosci ,2002,22:3070-3080.
[15] 赵晶,江伟.布比卡因心血管毒性机制及治疗的研究进展[J].临床麻醉学杂志,2008,24(5):453．
[16] 刘俊杰,赵俊.现代麻醉学[M] .第2版.北京:人民卫生出版社, 1997: 134.
[17] 庄心良,曾因明,陈伯銮.现代麻醉学[ M] .第三版.北京:人民卫生出版社,2003: 624.
[18] 毕文英.布比卡因过敏致休克患者的抢救与护理[J].中国社区医师,2012,14(4):361.
[19] Food and Drug Administration.Bupivacaine hydrochloride injection label[EB/OL].[2012-01-31].http://www.accessdata.fda.gov/drugsatfda_docs/label/2012/018692s015lbl.pdf
[20] Medicines and Healthcare Products Regulatory Agency. Summary of procuct characteristics[EB/OL].[2014-02-18].http://www.mhra.gov.uk/home/groups/spcpil/documents/spcpil/con1399706952898.pdf